Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 7:03 PM
Ignite Modification Date:
2025-12-25 @ 4:36 PM
NCT ID:
NCT01663857
Group ID:
EG002
Title:
Phase 2: Arm A: LY2228820 + Gemcitabine + Carboplatin
Description:
Arm A: LY2228820 200 mg orally every 12 hr. on Days 1-10
Gemcitabine 1000 mg/m2 IV over 30 min. on Days 3 and 10
Carboplatin AUC 4 (maximum dose 600mg) IV over 30 min. on Day 3
Arm A: LY2228820 300 mg orally every 12 hr. on Days 1-14 of a 28 day cycle (Cycles 7+)
Deaths Number Affected:
30
Deaths Number At Risk:
None
Serious Number Affected:
26
Serious Number At Risk:
58
Other Number Affected:
58
Other Number At Risk:
58
Study:
NCT01663857
Results Section:
NCT01663857
Adverse Events Module:
NCT01663857